Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma

SIMPLE SUMMARY: Medulloblastoma is the most frequent pediatric brain cancer. Despite great improvements in the treatment of this disease over the last decades, survivors are subject to debilitating adverse effects that strongly impair their quality of life. There is an urgent need to find efficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagnuzzi-Boncompagni, Marina, Picco, Vincent, Vial, Valérie, Planas-Bielsa, Victor, Vandenberghe, Ashaina, Daubon, Thomas, Derieppe, Marie-Alix, Montemagno, Christopher, Durivault, Jérôme, Grépin, Renaud, Martial, Sonia, Doyen, Jérôme, Gavard, Julie, Pagès, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750527/
https://www.ncbi.nlm.nih.gov/pubmed/35008234
http://dx.doi.org/10.3390/cancers14010070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750527/
https://www.ncbi.nlm.nih.gov/pubmed/35008234
http://dx.doi.org/10.3390/cancers14010070

Ejemplares similares